Spotlight Stock,Trends & Articles MindMed Launches MDMA Program Targeting Autism Spectrum Disorder and Social Anxiety By Dennis Mutua October 27, 2021 Psychedelic biotech company developing psychedelic-assisted therapies to treat mental conditions and addictions MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) has launched R(-)-MDMA program which aims at treating social anxiety and funct...
Featured,Trends & Articles John Hopkins Medicine Given $4M to Study Psilocybin as a Therapy to Quit Smoking By Dennis Mutua October 25, 2021 John Hopkins Medicine announced having received $4 million from the National Institute of Health (NIH) to assist researchers from the University in studying how psilocybin can be used as a therapy to help individuals quit smoking....
Spotlight Stock,Trends & Articles Small Pharma Granted UK Approval for DMT-Assisted Therapy for MDD By Dennis Mutua October 22, 2021 Pharmaceutical company specializing on developing novel treatments for mental health conditions Small Pharma Inc. (CVE: DMT) (OTCQB: DMTTF) having been granted an innovation passport designation for SPL026 the lead product candida...
Featured,Trends & Articles UK PM Boris Johnson to Consider Calls to Decriminalize Psilocybin By Dennis Mutua October 21, 2021 The Prime Minister on UK, Boris Johnson says that he will consider the growing calls to decriminalize magic mushroom product commonly referred to as psilocybin in the country. Boris made these sentiments after Tory Member of Parli...
Spotlight Stock,Trends & Articles Cybin Completes 74th Pre-Clinical Study of Psychedelic Molecules By Dennis Mutua October 20, 2021 Life sciences company specializing on progressing psychedelic therapeutics by utilizing drug discovery platforms Cybin Inc. (NEO: CYBN) (NYSE American : CYBN) announced having completed its 74th preclinical study into psychedelic ...
Featured,Trends & Articles Nushama a New Psychedelics Wellness Center in New York Providing Ketamine Treatment By Dennis Mutua October 18, 2021 A newly established psychedelics wellness center in New York City, Nushama Psychedelic Wellness Center, is providing medically controlled treatments for patients suffering from chronic pain, anxiety, trauma-induced mood disorders ...
Spotlight Stock,Trends & Articles Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer in the Company By Dennis Mutua October 15, 2021 Emerging integrative wellness company focusing on changing traditional mental healthcare and addictions trough use of psychedelics Levitee Labs Inc. (CSE: LVT) (OTCPINK: LVTTF) announced having appointed Dr. Mohammed H. Mosli the ...
Spotlight Stock,Trends & Articles Cybin Submits International Patent Application For Psychedelic Delivery Methods By Dennis Mutua October 14, 2021 Life Sciences company focused on advancing psychedelic therapeutics by capitalizing on drug development, unique delivery mechanisms and improved novel compounds Cybin Inc. (NEO: CYBN) (NYSEAMERICAN: CYBN) announced having submitte...